Matches in Wikidata for { <http://www.wikidata.org/entity/Q105789421> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q105789421 description "clinical trial" @default.
- Q105789421 description "ensayo clínico" @default.
- Q105789421 description "ensayu clínicu" @default.
- Q105789421 description "klinisch onderzoek" @default.
- Q105789421 description "клінічне випробування" @default.
- Q105789421 description "կլինիկական փորձարկում" @default.
- Q105789421 description "临床试验" @default.
- Q105789421 name "A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation" @default.
- Q105789421 name "A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation" @default.
- Q105789421 type Item @default.
- Q105789421 label "A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation" @default.
- Q105789421 label "A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation" @default.
- Q105789421 prefLabel "A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation" @default.
- Q105789421 prefLabel "A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation" @default.
- Q105789421 P1132 Q105789421-3E61A0DC-D516-4BEE-9186-B92537B0CCA1 @default.
- Q105789421 P1476 Q105789421-62ED2B23-C392-4437-A83F-0F3460658F01 @default.
- Q105789421 P2899 Q105789421-2C3F0782-54C9-4D6D-9E40-AA32D31ABC11 @default.
- Q105789421 P3098 Q105789421-DED28265-0413-4B5A-82A4-9D90D0F56630 @default.
- Q105789421 P31 Q105789421-1642AF0A-6D36-4151-9C50-86750330D7DD @default.
- Q105789421 P4844 Q105789421-44B8BBBF-1765-4B89-80A0-40987C5CC1CC @default.
- Q105789421 P580 Q105789421-C5D876C6-9DBB-4FD9-8601-C7415FF622BD @default.
- Q105789421 P582 Q105789421-7A5030F7-5D79-4CFB-A17F-BEE2EDAF1034 @default.
- Q105789421 P6099 Q105789421-DAEA2939-13E9-48E0-97FC-4BE0EEB3E15A @default.
- Q105789421 P8005 Q105789421-332265C7-04A5-47A6-A4D6-B861D452FBAE @default.
- Q105789421 P8363 Q105789421-0E9C29C6-0513-48F5-B936-8207EC89B70E @default.
- Q105789421 P859 Q105789421-66F63DF4-EEAD-496A-B614-2058B8851AD6 @default.
- Q105789421 P1132 "+95" @default.
- Q105789421 P1476 "A Phase 1 Open-label Dose Escalation Trial of BI 1701963 in Combination With Irinotecan in KRAS Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer" @default.
- Q105789421 P2899 "+18" @default.
- Q105789421 P3098 "NCT04627142" @default.
- Q105789421 P31 Q30612 @default.
- Q105789421 P4844 Q412197 @default.
- Q105789421 P580 "2020-11-23T00:00:00Z" @default.
- Q105789421 P582 "2022-10-30T00:00:00Z" @default.
- Q105789421 P6099 Q5452194 @default.
- Q105789421 P8005 Q76649708 @default.
- Q105789421 P8363 Q78089383 @default.
- Q105789421 P859 Q699532 @default.